Page 9 - Development of the mixed-use precinct and 1 500-bed student accommodation at Sefako Makgatho Health Sciences University
P. 9
8
Name & demographics Topic Supervisor
Blaise Lukau Exploring knowledge, attitudes and practices Dr Burt Davis
(DRC, black male) regarding post-exposure prophylaxis against HIV
among healthcare workers at Mokhotlong Hospital
in Lesotho: A mixed-methods study
Makhala Nts’asa Moabi Perceptions of pregnant women on the elimination Dr Munya
(Lesotho, black female) of mother-to-child transmission of HIV in Morija Saruchera
town of Maseru in Lesotho
Teboho Mohlabi An exploration of the barriers and enablers to the Dr Chioma
(South Africa, black uptake of HIV testing services by male street Ohajunwa
male) vendors in Maseru, Lesotho
Mokgadi Mojela Counsellors’ perceptions on the effectiveness of Dr Burt Davis
(South Africa, black online platforms to address mental health and
female) wellness, including issues linked to HIV/Aids
Makoloi Nakedi Challenges faced by community healthcare workers Dr Burt Davis
(South Africa, black in providing healthcare services to households in the
female) Emfuleni sub-district, Gauteng province
Zinhle Ngubane Exploring the factors that affect adherence to Dr Chioma
(South Africa, black antiretroviral therapy among adult individuals living Ohajunwa
female) with HIV/Aids at the Pomeroy Community Health
Centre HAST (HIV/Aids, STIs & TB) clinic
Lineo Nyenye Evaluating tuberculosis prevention therapy Dr Burt Davis
(Lesotho, black female) knowledge levels and attitudes among miners/ex-
miners in the Leribe district of Lesotho
Nontembeko Sibandze Factors influencing the uptake, adherence and Dr Burt Davis
(Swaziland, black persistence of adolescent girls and young women on
female) pre-exposure prophylaxis (PrEP) in the DREAMS
implementation sites in the Shiselweni region of
Eswatini: The perspectives of key stakeholders
Hlapase Tesele Exploring the financial vulnerabilities of sex workers Dr Mzingaye
(Lesotho, black female) during the Covid-19 pandemic in Lesotho: Xaba
Implications for HIV/Aids
Annual Report 2024 – March 2025